Antidote is a digital health company on a mission to accelerate medical research. In a world where 80% of clinical trials are delayed or closed due to lack of participants, Antidote uses precision recruitment to match the right patients with the right trials. Antidote strikes the right balance between technology and human touch to deliver high-quality patient engagement through the integration of data-driven technologies, digital expertise, deep domain experience, a diverse partner network, and personalized patient and site services. Antidote was launched as TrialReach and is based in the US and UK. For more information, please visit www.antidote.me.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Antidote Match; patient recruitment services
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):